Nerve Injury and Regeneration

Peripheral nerve injury is common in trauma and as a surgical complication. The biological response to the injury is what predicts recovery and decides the surgical indication: the nerve's capacity to regenerate depends on the severity of the injury, the timing of repair and whether the endoneurial architecture has been preserved.

Scope. This page covers the injury and repair biology: the classifications, Wallerian degeneration, chromatolysis, Schwann-cell reprogramming and regeneration. The underlying structure, conduction and fibre-type basic science (neurone, myelin, nodes of Ranvier, saltatory conduction, endoneurium/perineurium/epineurium, A-alpha through C fibres) is covered on the Nerve Anatomy and Physiology page, and the operative techniques this biology informs (epineurial versus fascicular repair, grafts, conduits and transfers) on the Nerve Repairs page; the three are companion reads.

Why the biology matters. The Seddon and Sunderland classifications set the expected recovery, and electrodiagnostics tell the types apart. Timing follows from the same biology: primary repair within 3 months is optimal, because delay allows the endoneurial tubes to fibrose and the target muscle to atrophy, and after 18-24 months motor recovery is unlikely even with a perfect repair.

The three processes. Regeneration depends on three biological processes working in concert: Wallerian degeneration in the distal stump, chromatolysis in the proximal cell body, and axonal regeneration by the growth cone. All three must succeed for functional recovery. Wallerian degeneration without regeneration leaves the targets denervated, chromatolysis without successful reinnervation leads to neuronal death, and growth-cone navigation without intact endoneurial tubes produces a neuroma.

The sheaths. From inside out: endoneurium around each axon, perineurium around each fascicle, epineurium around the whole trunk. Each is a surgical fact as much as a histological one. The endoneurial tube is the guide a regenerating axon follows; the perineurium is the blood-nerve barrier and the source of the nerve's tensile strength; the epineurium is where the blood supply enters and the surgical plane for nerve repair. Injury to the deeper layers causes more misdirection during regeneration.

Schwann cells. In a myelinated fibre one Schwann cell makes one internode of myelin, 1-2 mm long, with a node of Ranvier between internodes; conduction is saltatory and fast. In an unmyelinated fibre one Schwann cell wraps several axons, and conduction is slower.

Blood supply, and why tension matters. Extrinsic segmental vessels from the adjacent arteries enter through the epineurium, and an intrinsic longitudinal network within the epineurium gives the nerve redundancy. That longitudinal network is what keeps a nerve alive when it is mobilised: mobilisation over several centimetres is safe, but excessive stretch disrupts the intrinsic supply. At a repair, tension over 10% gap strain causes ischaemia at the repair site, then fibrosis, then failure, which is why a gap that cannot be closed without tension is grafted rather than repaired under tension.

Fascicles. Small nerves such as the digital nerves are monofascicular; most peripheral nerves are oligofascicular with 2-5 fascicles; the major trunks (the median and ulnar at the wrist) are polyfascicular, many fascicles joined by plexiform connections. Proximally, motor and sensory fascicles are intermixed and difficult to match at repair; distally they separate and are easier to identify, which is part of why distal repairs do better.

Seddon's three types and Sunderland's five degrees describe the same spectrum from two directions: Seddon from what recovers, Sunderland from which sheath is torn. The question to ask of any injury is whether the axon is in continuity and, if not, whether the endoneurial tube around it survived.

View larger

Wallerian degeneration is the breakdown of axon and myelin distal to a nerve injury, named after Augustus Waller, who described it in 1850. It is an active process rather than passive decay, and it needs Schwann cells and macrophages to carry it out. It begins within 24-48 hours and is the necessary first step of regeneration in every injury that has divided the axon.

View larger

The axon. Calcium influx triggers the breakdown, through calpain-mediated degradation of the cytoskeleton, and the ubiquitin-proteasome system degrades the axonal proteins. The axon fragments into ellipsoids and the myelin breaks down into lipid droplets.

The cells. Schwann cells phagocytose 40-50% of the debris themselves and secrete the chemokines CCL2 and MCP-1 to recruit macrophages for the rest. If denervation is prolonged, endoneurial fibroblasts proliferate and the tube fibroses.

Chromatolysis is the morphological and metabolic response of the neuronal cell body to axonal injury: the neurone switches from neurotransmission mode to regeneration mode. It occurs in the dorsal root ganglion (sensory) and anterior horn (motor) cell bodies and peaks at 7-14 days.

What you see on Nissl staining. The word means dissolution of colour on the Nissl stain, and that is the first feature:

1. Nissl substance dispersal - ribosomes and rough endoplasmic reticulum move from the centre to the periphery
2. Nuclear eccentricity - the nucleus moves to the cell periphery
3. Cell body swelling - volume increases by 30-50%
4. Nucleolar enlargement - reflecting increased protein synthesis

What is happening underneath. Neurotransmitter genes (acetylcholine, neurotransmitter receptors) are downregulated and growth-associated genes are upregulated: GAP-43, tubulin, actin and other cytoskeletal proteins. Protein synthesis rises, with more ribosomal RNA and an expanded rough endoplasmic reticulum; the transcription factors ATF3, c-Jun and STAT3 drive the regeneration programme; and axonal transport is enhanced by upregulated kinesin and dynein motors.

Read it as a positive sign. Chromatolysis indicates that the cell has survived and is attempting to regenerate; its absence after nerve injury suggests cell death. Prolonged chromatolysis beyond 3-4 weeks without successful regeneration leads to neuronal atrophy and eventual apoptosis.

Schwann cells are the glial cells of the peripheral nervous system, and after injury they undergo a dramatic phenotypic transformation to support regeneration. They do four jobs.

Debris clearance. They express phagocytic receptors and phagocytose myelin and axonal debris alongside the macrophages they have recruited.

Bands of Büngner. They align in columns within the endoneurial tubes, forming tubular scaffolds that physically direct regenerating axons toward their original targets. Without endoneurial tubes, as in neurotmesis, the bands collapse and a neuroma forms.

Neurotrophic support. They secrete NGF (nerve growth factor), BDNF (brain-derived neurotrophic factor), GDNF (glial-derived neurotrophic factor), CNTF (ciliary neurotrophic factor) and FGF (fibroblast growth factor), creating the chemical gradient that guides the growth cone.

Remyelination. Once axonal contact is re-established they transition back to a myelinating phenotype and remyelinate the regenerated axon. The new internodes are shorter and the myelin thinner than the original, which is why conduction velocity is slower after regeneration.

The molecular switch. The transcription factor c-Jun is the master regulator of Schwann cell dedifferentiation and the pro-regenerative phenotype: c-Jun knockout mice show failed Wallerian degeneration and poor nerve regeneration. c-Jun upregulation drives dedifferentiation, proliferation and growth factor secretion; Sox2 expression maintains the dedifferentiated state; neuregulin-1 signalling from the regenerating axon promotes remyelination; and laminin and fibronectin in the Schwann cell basal lamina provide the extracellular matrix cues for axonal growth.

The sequence. Within 24 hours the Schwann cell senses the loss of axonal contact, the absence of neuregulin-1 and other axonal signals. Over 1-3 days it downregulates the myelin genes (P0, MBP, PMP22), upregulates c-Jun and the growth factor genes, and begins to proliferate; over 3-7 days the dividing cells align into bands of Büngner within the endoneurial tubes and begin secreting neurotrophic factors. From 1-4 weeks the bands are maintained in a pro-regenerative state. Over the following months the cell either remyelinates an arriving axon or, if no axon has made contact by 3-4 months, the bands gradually deteriorate and the endoneurial tubes fibrose.

Neurotrophins and Their Receptors

The growth factors the repair Schwann cells secrete act on the regenerating neurone only through specific cell-surface receptors, and the ligand-receptor pairing is high-yield basic science.

• Trk (tropomyosin-receptor-kinase) receptors are high-affinity receptor tyrosine kinases, each matched to a neurotrophin:
  • TrkA binds NGF (nerve growth factor) - small sensory and sympathetic neurones
  • TrkB binds BDNF and NT-4/5 - motor and many sensory neurones
  • TrkC binds NT-3 (neurotrophin-3) - large proprioceptive neurones
• GDNF signals through a distinct two-part receptor, the GFR-alpha-1 co-receptor together with the RET receptor tyrosine kinase, and is particularly important for motor and sensory neurone survival after axotomy.
• p75NTR is the low-affinity pan-neurotrophin receptor, a TNF-receptor-superfamily member that binds all the neurotrophins and their immature pro-forms.

On ligand binding a Trk receptor dimerises and autophosphorylates, activating PI3K/Akt (survival), Ras/MAPK (growth and differentiation) and PLC-gamma signalling, which drives neuronal survival, axonal elongation and growth-cone advance.

p75NTR modulates Trk signalling, sharpening ligand specificity and enhancing high-affinity binding, but when expressed without a partnering Trk it can instead trigger apoptosis. It is strongly re-expressed by injured neurones and by repair Schwann cells, so it contributes both to regeneration support and, in a neurone that fails to reconnect, to programmed cell death.

Axonal regeneration begins within days of injury. The proximal axon stump forms a growth cone at its tip, which extends processes (filopodia and lamellipodia) that sense the local environment and navigate toward the target.

The growth cone is a specialised structure at the regenerating axon tip:

• Filopodia - thin finger-like projections extending 10-50 micrometres, sensing chemical and physical cues
• Lamellipodia - sheet-like membrane expansions between the filopodia, providing surface for advancement
• Receptors - Trk receptors for neurotrophins (NGF, BDNF, GDNF), integrins for extracellular matrix, semaphorin receptors, ephrin receptors
• Cytoskeletal machinery - actin filaments in the filopodia, microtubules in the central domain, motor proteins (myosin, kinesin) for advancement

The sequence. From a sealed stump to a mature, remyelinated axon takes six steps, and the clock on each is worth knowing:

1. Proximal stump sealing (0-24 hours) - calcium influx triggers membrane sealing at the injury site
2. Growth cone formation (24-72 hours) - multiple sprouts emerge from the proximal stump, up to 20-50 initially
3. Endoneurial tube entry (3-7 days) - the sprouts that enter endoneurial tubes advance; the others retract
4. Elongation (weeks to months) - the growth cone extends at 1-3 mm per day along the bands of Büngner
5. Target contact (months) - the growth cone reaches the target (muscle, skin receptor) and forms a synapse
6. Maturation (months to years) - axon diameter increases, Schwann cells remyelinate, conduction velocity improves

What limits it. Distance first: a proximal injury (brachial plexus, sciatic nerve) needs months to years for the growth cone to reach its distal targets, and the clinical rule of thumb is 1 mm per day, an inch a month. Age next: the rate is 1-3 mm per day in youth and slower in the elderly. And time: muscle fibres and Schwann cells atrophy once denervation exceeds 12-18 months.

GAP-43: The Axonal Growth Marker

GAP-43 is one of the growth-associated genes the injured cell body upregulates, and it is the prototypical molecular marker of axonal regeneration.

What it is. GAP-43 (growth-associated protein 43, also called neuromodulin or B-50) is a membrane-associated phosphoprotein highly concentrated in the growth cone and the axonal plasma membrane. Its expression is low in mature, stable neurones and is strongly upregulated by the injured cell body as it switches from a transmission phenotype to a growth phenotype.

What it does. It regulates the actin cytoskeleton and membrane dynamics at the growth cone. It binds calmodulin and is a major substrate of protein kinase C (PKC); its phosphorylation state modulates filopodial extension, growth-cone motility and the axon's capacity to advance and form new connections. It is part of the structural machinery of regeneration, not merely a passive label.

Why it is used. Because GAP-43 rises specifically when an axon is actively elongating, it serves experimentally as a readout of genuine regeneration and helps distinguish a regenerating neurone from one destined to atrophy: it is the molecular counterpart of the clinically advancing Tinel sign.

Success depends on patient, injury and surgical factors, and understanding them is what lets the surgeon optimise the repair and set realistic expectations.

Nerve conduction studies. The distal responses answer the Seddon question, but only once Wallerian degeneration has had time to happen: a study done in the first week can be normal distal to a complete transection. Stimulation across the lesion is what shows a conduction block.

Electromyography. The baseline study is at 3-4 weeks. Denervation potentials - spontaneous fibrillation potentials and positive sharp waves - are present in axonotmesis and neurotmesis and absent in neurapraxia. Motor units show reduced recruitment initially, and then large polyphasic units as reinnervation occurs; on follow-up at 3-month intervals, nascent units are the sign that reinnervation has begun.

Imaging answers a different question, continuity, and is chosen by where the nerve is.

Intraoperative nerve action potentials. Stimulate proximal to the lesion and record distal to it. A NAP present means axons are conducting across the lesion and the nerve is observed; a NAP absent means no conduction, and the lesion needs repair or grafting. The recording needs 5000 or more conducting axons to register a signal.

Intraoperative stimulation. Motor stimulation distal to the injury that produces a response shows that some axons are intact distally, but it is valid only within 72 hours, before Wallerian degeneration removes the distal axons. Stimulating proximally and recording distally confirms the level of the lesion and guides how far the exploration extends.

Algorithm

View larger

The decision. Open or closed, and if closed, recovering or not. An open injury with a divided nerve is explored and repaired. A closed injury is given time, because a neurapraxia recovers and an axonotmesis with intact tubes regenerates without surgery, and the signs of recovery arrive within three months.

Non-operative care for neurapraxia and closed axonotmesis is splinting to prevent contractures, physiotherapy for joint mobility, serial clinical examination of the Tinel sign, and EMG at 3-4 weeks for a baseline with a follow-up at 3 months. Recovery is declared by an advancing Tinel, nascent motor unit potentials on EMG, and clinical recovery appropriate to the regeneration distance.

Surgery is indicated outright by three findings and considered for three more.

Absolute

• Open injury with nerve discontinuity
• Progressive neurological deficit
• Associated vascular injury requiring exploration

Relative

• No clinical or EMG recovery by 3-4 months
• Stationary Tinel sign
• Neuroma-in-continuity on imaging

The repair options, chosen by the gap and the distance to the target:

Timing. The biology sets the windows: fresh nerve ends and minimal fibrosis early, Schwann cell bands still viable through the first three months, then declining guidance and advancing muscle atrophy.

Nerve transfer is considered when the injury is proximal (brachial plexus, high sciatic), when the time to target would exceed 18 months, or when a root avulsion leaves no proximal stump to graft from. It is placed close to the target muscle, so reinnervation is fast, and it should be performed within 6 months for the best outcome; the common transfers are tabulated under Surgical Technique.

Reconstruction is what remains when nerve repair is not viable: tendon transfers for motor function, arthrodesis for joint stability, free functioning muscle transfer, and sensory substitution procedures. None of these is time-dependent in the way regeneration is, so they can be performed late.

The painful neuroma is disordered axonal sprouting at the injury site; tapping it causes severe lancinating pain. It forms at amputation stumps and failed repairs. Prevention is a tension-free repair, nerve ends covered in vascularised tissue, and buried relocation for the amputation neuroma.

Neuropathic pain and CRPS. Complex regional pain syndrome can follow any nerve injury, with burning pain, allodynia and autonomic changes. Management is early mobilisation and desensitisation, mirror therapy and TENS, gabapentin, pregabalin or duloxetine, and multidisciplinary pain management.

The repair is protected for three weeks and mobilised over the next three; after that the work is keeping the joints supple and the scar soft while reinnervation is awaited.

Splinting protects the repair from tension, prevents joint contracture and holds the hand in the position of function. The rigid splint stays for 3 weeks, a removable splint for 3-6 weeks, and a night splint until reinnervation.

Therapy. The early phase (0-6 weeks) is oedema control, scar management, passive range of motion of the uninvolved joints and desensitisation if the limb is hypersensitive; from 6 weeks the work is active range of motion, strengthening once the motor returns, and sensory re-education. Strengthening progresses from isometric work when a flicker appears, to isotonic work against gravity at M3, to resistance training at M4; EMG biofeedback helps weak muscles, mirror therapy helps cortical reorganisation, and electrical stimulation is of controversial efficacy.

Sensory re-education begins with constant-touch localisation, moving-touch identification and texture grading as protective sensation returns, and progresses to object recognition, functional activity training and adaptive techniques if recovery is incomplete.

By level. After a distal injury at the wrist or hand, M4-M5 is achievable and S3+ is common. After a proximal injury in the arm or plexus, M3-M4 is typical, S3 is often the best achieved, and intrinsic muscle recovery is rare.

Sensation. Protective sensation usually recovers; fine discriminative sensation is often impaired, and cold intolerance is common. Two-point discrimination grades the result: normal is under 6 mm, functional 6-12 mm, and protective over 12 mm.

Grafts do generally 10-20% worse than primary repair, and the shorter the graft the better; cable grafts serve the larger nerves. Autograft remains the gold standard with a 60-70% good outcome; processed allograft does similarly for gaps under 3 cm, and for longer gaps autograft is preferred.

Transfers reinnervate faster because they are close to the target, bypass the damaged proximal pathway and work even after root avulsion, provided the donor nerve is intact. The Oberlin transfer restores elbow flexion to M4 or better in 80-90%, and spinal accessory to suprascapular succeeds in 70-80%.

The biology translates directly into three clinical questions: which Seddon type is this, is it a nerve injury at all, and when will the axons arrive.

Which type. The bedside picture, the EMG at 3 weeks and the behaviour of the Tinel sign together separate the three Seddon types:

Is it a nerve injury. Acute focal weakness and sensory loss has mimics. A peripheral nerve injury maps to one named nerve; the mimics are told apart by a distribution that does not, or by signs a nerve injury does not produce.

When the axons will arrive. Measure the distance from the injury to the target, divide by the regeneration rate and add the 2-3 weeks the cell body spends in chromatolysis before the axon sets off. Two worked examples:

• Median nerve laceration at the wrist, 12 cm to the thenar muscles: 12 cm at 1 mm per day is 120 days (4 months); add chromatolysis and the first motor recovery is at about 5 months, with strength continuing to improve for 12-18 months
• Brachial plexus injury at Erb's point, 35 cm to the hand intrinsics: 350 days (11.5 months); add chromatolysis and the first motor recovery would be at 12-13 months, which exceeds the 18-24 month motor endplate viability: poor prognosis

Key Research Articles

1. Waller A. Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, and observations of the alterations produced thereby in the structure of their primitive fibres. Phil Trans R Soc Lond. 1850;140:423-429. doi:10.1098/rstl.1850.0021

2. Seddon HJ. Three types of nerve injury. Brain. 1943;66(4):237-288. doi:10.1093/brain/66.4.237

3. Sunderland S. A classification of peripheral nerve injuries producing loss of function. Brain. 1951;74(4):491-516. doi:10.1093/brain/74.4.491

4. Vargas ME, Barres BA. Why is Wallerian degeneration in the CNS so slow? Annu Rev Neurosci. 2007;30:153-179. doi:10.1146/annurev.neuro.30.051606.094354

5. Jessen KR, Mirsky R. The repair Schwann cell and its function in regenerating nerves. J Physiol. 2016;594(13):3521-3531. doi:10.1113/JP270874

6. Arthur-Farraj PJ, Latouche M, Wilton DK, et al. c-Jun reprograms Schwann cells of injured nerves to generate a repair cell essential for regeneration. Neuron. 2012;75(4):633-647. doi:10.1016/j.neuron.2012.06.021

7. Gordon T, Tyreman N, Raji MA. The basis for diminished functional recovery after delayed peripheral nerve repair. J Neurosci. 2011;31(14):5325-5334. doi:10.1523/JNEUROSCI.6156-10.2011

8. Fu SY, Gordon T. The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol. 1997;14(1-2):67-116. doi:10.1007/BF02740621

9. Rosberg HE, Carlsson KS, Höjgård S, et al. Injury to the human median and ulnar nerves in the forearm - analysis of costs for treatment and rehabilitation of 69 patients in southern Sweden. J Hand Surg Br. 2005;30(1):35-39. doi:10.1016/j.jhsb.2004.09.003

10. Brushart TM. Nerve Repair. Oxford University Press. 2011. (Comprehensive textbook on peripheral nerve biology and repair)

11. Lundborg G. A 25-year perspective of peripheral nerve surgery: evolving neuroscientific concepts and clinical significance. J Hand Surg Am. 2000;25(3):391-414. doi:10.1053/jhsu.2000.4165

12. Lee SK, Wolfe SW. Peripheral nerve injury and repair. J Am Acad Orthop Surg. 2000;8(4):243-252. doi:10.5435/00124635-200007000-00005

13. Boyd JG, Gordon T. Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury. Mol Neurobiol. 2003;27(3):277-324. doi:10.1385/MN:27:3:277

14. Griffin JW, Thompson WJ. Biology and pathology of nonmyelinating Schwann cells. Glia. 2008;56(14):1518-1531. doi:10.1002/glia.20778

15. Scheib J, Höke A. Advances in peripheral nerve regeneration. Nat Rev Neurol. 2013;9(12):668-676. doi:10.1038/nrneurol.2013.227

16. Jaquet JB, Luijsterburg AJ, Kalmijn S, et al. Median, ulnar, and combined median-ulnar nerve injuries: functional outcome and return to productivity. J Trauma. 2001;51(4):687-692. doi:10.1097/00005373-200110000-00011

17. Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR). Hip, Knee & Shoulder Arthroplasty: 2024 Annual Report. Adelaide: AOA; 2024. (For context on surgical outcomes research standards)

Suggested Reading

18. Mackinnon SE, Dellon AL. Surgery of the Peripheral Nerve. Thieme Medical Publishers. 1988. (Classic text on peripheral nerve surgery)

19. Spinner RJ, Kline DG. Surgery for peripheral nerve and brachial plexus injuries or other nerve lesions. Muscle Nerve. 2000;23(5):680-695. doi:10.1002/(SICI)1097-4598(200005)23:5

20. Terenghi G. Peripheral nerve regeneration and neurotrophic factors. J Anat. 1999;194(Pt 1):1-14. doi:10.1046/j.1469-7580.1999.19410001.x